300759SZSE

2025 Annual Internal Control Evaluation Report

✨ AI Summary

This report evaluates the effectiveness of internal controls at Pharmaron (Beijing) New Drug Technology Co., Ltd. as of December 31, 2025. The board confirms no significant deficiencies in financial or non-financial reporting controls. The evaluation involved comprehensive testing across various departments, ensuring compliance with internal control standards. The company aims to enhance operational efficiency while maintaining legal compliance and safeguarding assets.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Important Statement

According to the regulations of the enterprise internal control standard system, establishing, improving, and effectively implementing internal controls, evaluating their effectiveness, and truthfully disclosing the internal control evaluation report is the responsibility of the company's board of directors. The audit committee supervises the establishment and implementation of internal controls by the board. The management is responsible for organizing and leading the daily operation of internal controls. The board of directors and senior management guarantee that the content of this report does not contain any false records, misleading statements, or significant omissions, and they bear legal responsibility for the truthfulness, accuracy, and completeness of the report's content. The goal of the company's internal control is to reasonably ensure that business management is legal and compliant, assets are secure, financial reporting and related information are true and complete, operational efficiency and effectiveness are improved, and the development strategy is promoted. Due to the inherent limitations of internal controls, they can only provide reasonable assurance of achieving the above objectives. Furthermore, changes in circumstances may lead to internal controls becoming inappropriate or a decrease in adherence to control policies and procedures, making it risky to infer the future effectiveness of internal controls based on evaluation results.

Internal Control Evaluation Conclusion

Based on the identification of significant deficiencies in internal controls over financial reporting, as of the evaluation report benchmark date, there are no significant deficiencies in the internal controls over financial reporting. The company has maintained effective internal controls over financial reporting in all material respects in accordance with the enterprise internal control standard system and relevant regulations. Based on the identification of significant deficiencies in internal controls over non-financial reporting, as of the evaluation report benchmark date, the company has not identified any significant deficiencies in non-financial reporting internal controls. No factors affecting the evaluation conclusion of internal control effectiveness have occurred between the evaluation report benchmark date and the date of issuance of the evaluation report.

Internal Control Evaluation Work Situation

In 2025, the company conducted internal control evaluations following the principles of comprehensiveness, materiality, and objectivity. Led by the internal control and internal audit department, colleagues from the group headquarters, subsidiaries, and various departments participated extensively. The evaluation involved on-site observations, business interviews, physical inventory checks, financial data analysis, and transaction document sampling to comprehensively and systematically assess the efficiency and effectiveness of the design and execution of the company's internal control system.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.